The control of invasive Candida infection in very low birth weight infants by reduction in the use of 3rd generation cephalosporin

Korean Journal of Pediatrics

Volumn 56, Issue 2, 2013, Pages 68-74

  Chang, Yu Jin ^a   Choi, Il Rak ^a   Shin, Won Sub ^a   Lee, Jang Hoon ^a   Kim, Yun Kyung ^b   Park, Moon Sung ^a  

^a Ajou University School of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Invasive candidiasis; Nosocomial infection; Sepsis; Very low birth weight infant

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CARBAPENEM; CEPHALOSPORIN; HISTAMINE H2 RECEPTOR ANTAGONIST; VANCOMYCIN; VORICONAZOLE;

ARTICLE; CENTRAL VENOUS CATHETERIZATION; DRUG DOSE REDUCTION; DRUG USE; ENDOTRACHEAL INTUBATION; FEMALE; FOLLOW UP; GESTATIONAL AGE; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFANT; INVASIVE CANDIDIASIS; KLEBSIELLA OXYTOCA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; MORTALITY; NEWBORN; NEWBORN SEPSIS; OBSERVATIONAL STUDY; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT;

EID: 84875057676     PISSN: 17381061     EISSN: 20927258     Source Type: Journal    
DOI: 10.3345/kjp.2013.56.2.68     Document Type: Article

References (36)

1. Perez-Gonzalez LF, Ruiz-Gonzalez JM, Noyola DE. Nosocomial bacteremia in children: a 15-year experience at a general hospital in Mexico. Infect Control Hosp Epidemiol 2007;28:418-22.
2. Bartels DB, Schwab F, Geffers C, Poets CF, Gastmeier P. Nosocomial infection in small for gestational age newborns with birth weight<1500 g: a multicentre analysis. Arch Dis Child Fetal Neonatal Ed 2007;92:F449-53.
3. Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B. Epidemio logical, clinical, and microbiological characteristics of lateonset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics 2002;109:34-9.
4. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Lateonset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110(2 Pt 1):285-91.
5. Saiman L, Ludington E, Pfaller M, Rangel-Frausto S, Wiblin RT, Dawson J, et al. Risk factors for candidemia in neonatal intensive care unit patients. The National Epidemiology of Mycosis Survey Study Group. Pediatr Infect Dis J 2000;19:319-24.
6. Manzoni P, Jacqz-Aigrain E, Rizzollo S, Franco C, Stronati M, Mostert M, et al. Antifungal prophylaxis in neonates. Early Hum Dev 2011;87 Suppl 1:S59-60.
7. Manzoni P, Farina D, Leonessa M, d'Oulx EA, Galletto P, Mostert M, et al. Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization. Pediatrics 2006; 118:2359-64.
8. de Man P, Verhoeven BA, Verbrugh HA, Vos MC, van den Anker JN. An antibiotic policy to prevent emergence of resistant bacilli. Lancet 2000;355:973-8.
9. Kaiser JR, Cassat JE, Lewno MJ. Should antibiotics be discontinued at 48 hours for negative lateonset sepsis evaluations in the neonatal intensive care unit? J Perinatol 2002;22:445-7.
10. Karlowicz MG, Buescher ES, Surka AE. Fulminant lateonset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics 2000;106:1387-90.
11. Patel SJ, Oshodi A, Prasad P, Delamora P, Larson E, Zaoutis T, et al. Antibiotic use in neonatal intensive care units and adherence with Centers for Disease Control and Prevention 12 Step Campaign to Prevent Antimicrobial Resistance. Pediatr Infect Dis J 2009;28: 1047-51.
12. Brett S. Science review: the use of proton pump inhibitors for gastric acid suppression in critical illness. Crit Care 2005;9:45-50.
13. Gastmeier P, Geffers C, Schwab F, Fitzner J, Obladen M, Ruden H. Development of a surveillance system for nosocomial infections: the component for neonatal intensive care units in Germany. J Hosp Infect 2004;57:126-31.
14. Rubin LG, Sanchez PJ, Siegel J, Levine G, Saiman L, Jarvis WR, et al. Evaluation and treatment of neonates with suspected lateonset sepsis: a survey of neonatologists' practices. Pediatrics 2002; 110:e42.
15. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82:527-32.
16. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986;33:179-201.
17. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-34.
18. Clerihew L, Lamagni TL, Brocklehurst P, McGuire W. Invasive fungal infection in very low birthweight infants: national prospective surveillance study. Arch Dis Child Fetal Neonatal Ed 2006;91:F188-92.
19. Filioti I, Iosifidis E, Roilides E. Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients. Expert Opin Pharmacother 2008;9:3179-96.
20. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide sur veillance study. Clin Infect Dis 2004;39:309-17.
21. Lopez Sastre JB, Coto Cotallo GD, Fernandez Colomer B; Grupo de Hospitales Castrillo. Neonatal invasive candidiasis: a prospective multicenter study of 118 cases. Am J Perinatol 2003;20:153-63.
22. Long SS, Stevenson DK. Reducing Candida infections during neonatal intensive care: management choices, infection control, and fluconazole prophylaxis. J Pediatr 2005;147:135-41.
23. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001;345:1660-6.
24. Aziz M, Patel AL, Losavio J, Iyengar A, Berven M, Schloemer N, et al. Efficacy of fluconazole prophylaxis for prevention of invasive fungal infection in extremely low birth weight infants. Pediatr Infect Dis J 2010;29:352-6.
25. Healy CM, Campbell JR, Zaccaria E, Baker CJ. Fluconazole pro phylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazoleresistant Candida species. Pediatrics 2008;121:703-10.
26. Wade KC, Benjamin DK Jr, Kaufman DA, Ward RM, Smith PB, Jayaraman B, et al. Fluconazole dosing for the prevention or treat ment of invasive candidiasis in young infants. Pediatr Infect Dis J 2009;28:717-23.
27. Allen U, Richardson S, McGuire W, Bow E, Robinson J, Rotstein C, et al. Pediatric antifungal therapy. Part II: neonatal infections. Minerva Pediatr 2010;62:71-8.
28. Reed BN, Caudle KE, Rogers PD. Fluconazole prophylaxis in high-risk neonates. Ann Pharmacother 2010;44:178-84.
29. Alexander VN, Northrup V, Bizzarro MJ. Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing entero colitis. J Pediatr 2011;159:392-7.
30. Cotten CM, Taylor S, Stoll B, Goldberg RN, Hansen NI, Sanchez PJ, et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009;123: 58-66.
31. Bonnemaison E, Lanotte P, Cantagrel S, Thionois S, Quentin R, Chamboux C, et al. Comparison of fecal flora following admini stration of two antibiotic protocols for suspected maternofetal infection. Biol Neonate 2003;84:304-10.
32. Wang Y, Hoenig JD, Malin KJ, Qamar S, Petrof EO, Sun J, et al. 16S rRNA genebased analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J 2009; 3:944-54.
33. Claud EC, Walker WA. Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis. FASEB J 2001;15:1398-403.
34. Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, et al. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis 2000;30:662-78.
35. Kaufman DA. Challenging issues in neonatal candidiasis. Curr Med Res Opin 2010;26:1769-78.
36. Hwang JH, Choi CW, Chang YS, Choe YH, Park WS, Shin SM, et al. The efficacy of clinical strategies to reduce nosocomial sepsisin extremely low birth weight infants. J Korean Med Sci 2005;20: 177-81.